Opportunity
DIBBS #SPE2DP-26-T-4997
DLA Troop Support Solicitation for Lidocaine Hydrochloride Jelly, 2% (Sagent Pharmaceuticals)
Posted
September 11, 2026
Respond By
September 16, 2026
Identifier
SPE2DP-26-T-4997
NAICS
424210
This opportunity from the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain seeks Lidocaine Hydrochloride Jelly for medical use. - Government Buyer: - Defense Logistics Agency (DLA) - DLA Troop Support Medical Supply Chain - Pharmaceutical Field Support Activity, Philadelphia - Buyer: Timothy Mccauley - OEM Highlight: - SAGENT PHARMACEUTICALS, INC is the approved manufacturer - Vendors: - SAGENT PHARMACEUTICALS, INC - Products Requested: - Lidocaine Hydrochloride Jelly, 2% mucosal jelly - NSN: 6505-01-707-4169 - Part Number: NDC25021-0673-77 - Packaged as boxes of 10 each, 11ml applicators, 220 mg per 11 ml - Quantity: 2 boxes - Unique Requirements: - Delivery required within 20 calendar days, FOB destination - Sterile, single-use prefilled plastic syringes - Fast award process - No additional technical documents or attachments provided - Purchase request number: 7018260476
Description
LIDOCAINE HYDROCHLO (QTY: 2, NSN: 6505-01-707-4169, Purchase Request: 7018260476) Approved Sources: - CAGE: 4RP13, Part No: NDC25021-0673-77, Company: SAGENT PHARMACEUTICALS, INC